How have CANC shares performed this year?

Tema Oncology ETF's stock was trading at $26.40 at the beginning of the year. Since then, CANC shares have increased by 7.9% and is now trading at $28.48. View the best growth stocks for 2024 here .

How do I buy shares of Tema Oncology ETF?

Shares of CANC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

What other stocks do shareholders of Tema Oncology ETF own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Tema Oncology ETF investors own include Archer Aviation (ACHR) , Advanced Micro Devices (AMD) , Beam Therapeutics (BEAM) , CRISPR Therapeutics (CRSP) , Lockheed Martin (LMT) , NICE (NICE) and Intellia Therapeutics (NTLA) .

NASDAQ:CANC

Tema Oncology ETF (CANC) Price, Holdings, & News

$28.48

+0.60 (+2.15%)

(As of 10/11/2024 08:50 PM ET)

Compare

About Tema Oncology ETF (NASDAQ:CANC)

Advanced Chart

Get Tema Oncology ETF alerts:

Key Stats

Today's Range: $27.95
▼
$28.48
50-Day Range: $27.29
▼
$29.87
52-Week Range: $21.26
▼
$30.11
Volume: 3,000 shs
Average Volume: 7,296 shs
Market Capitalization: $49.56 million
Assets Under Management: $48.58 million
Dividend Yield: 0.49%
Net Expense Ratio: 0.75%
Aggregate Rating: Moderate Buy

ETF Overview

The Tema Oncology ETF (CANC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in stocks of companies focused on cancer treatment and management from issuers all around the world. The fund uses a bottom-up approach to select pioneering companies at perceived attractive valuations CANC was launched on Aug 15, 2023 and is issued by Tema.

Tema Oncology ETF Expenses

Type	CANC	Theme ETFs	Equity ETFs	NASDAQ ETFs	All ETFs
Management Fee	0.99%	0.57%	0.55%	0.49%	0.52%
Other Expenses	0.00%	0.57%	0.49%	0.41%	0.54%
Total Expense	0.99%	0.72%	0.71%	0.63%	0.71%
Fee Waiver	-0.24%	-0.75%	-0.52%	-0.32%	-0.57%
Net Expense	0.75%	0.59%	0.61%	0.56%	0.59%

Receive CANC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tema Oncology ETF and its competitors with MarketBeat's FREE daily newsletter.

CANC ETF News Headlines

Tema Oncology ETF (NASDAQ:CANC) Sees Significant Increase in Short Interest

October 11 at 4:42 AM | americanbankingnews.com

See More Headlines

CANC ETF - Frequently Asked Questions

: Tema Oncology ETF's stock was trading at $26.40 at the beginning of the year. Since then, CANC shares have increased by 7.9% and is now trading at $28.48.
View the best growth stocks for 2024 here.
: Shares of CANC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.
: Based on aggregate information from My MarketBeat watchlists, some other companies that Tema Oncology ETF investors own include Archer Aviation (ACHR), Advanced Micro Devices (AMD), Beam Therapeutics (BEAM), CRISPR Therapeutics (CRSP), Lockheed Martin (LMT), NICE (NICE) and Intellia Therapeutics (NTLA).